Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

NOAH calls for UK-EU vet medicine agreement
"Veterinary medicines must not be sidelined as a technical detail" - Dawn Howard, NOAH chief executive.
Political leaders will meet for a summit on 19 May.

The National Office of Animal Health (NOAH) has united with its EU counterpart, AnimalhealthEurope, to call for a veterinary medicines agreement between the UK and EU.

The groups warn that, since the UK's exit from the European Union, there has been no formal regulatory agreement on veterinary medicines.

They maintain that a veterinary agreement is vital not only for treating pets and livestock, but also to protect public health, ensure food security and support sustainable agriculture. Animal welfare in both the UK and the EU could be at risk.

A lack of regulatory co-operation is currently causing challenges which threaten product availability and innovation. While other regulatory agreements have diverged since Brexit, NOAH says that a lack of alignment in the veterinary medicines sector has caused unnecessary duplication, increased costs and risks to availability.

Political leaders are set to meet for the EU-UK Summit in London on 19 May 2025. NOAH and AnimalhealthEurope hope they will use the opportunity to agree on a dedicated veterinary medicines agreement.

The organisations suggest that the leaders could either agree on a standalone deal or include it as a specific chapter in a broader Sanitary and Phytosanitary (SPS) Agreement. NOAH and AnimalhealthEurope believe this will mean continued alignment across product authorisation, labelling, distribution and post-market surveillance.

Dawn Howard, chief executive of NOAH, said: “Veterinary medicines must not be sidelined as a technical detail—they are critical to the health of our animals, the safety of our food, and the growth of our economy.”

She added: “This moment is a great opportunity. The UK and the EU have the chance to show leadership in animal health and welfare, economic co-operation, and One Health. NOAH, together with AnimalhealthEurope, is ready to work with regulators and policymakers to secure this outcome.”

Roxane Feller, secretary general of AnimalhealthEurope, said: “Unlike politics, disease knows no borders. Guaranteed access to veterinary medicines is fundamental to safeguarding animal health and welfare, ensuring food security, and protecting public health under the One Health framework.

“AnimalhealthEurope, together with NOAH, has been calling for cooperation in the field of veterinary medicines since the publication of the Withdrawal Agreement and Political Declaration on the future relationship between the UK and the EU in 2018.”

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
BSAVA publishes fifth Manual of Canine and Feline Neurology

The BSAVA has published the fifth edition of its BSAVA Manual of Canine and Feline Neurology.

The new edition has been reviewed and updated, including new developments in diagnostics, therapeutic approaches and clinical decision-making. It is structured to support clinicians through diagnosis, treatment and long-term management.

The guide features five new chapters covering acute myelopathies, chronic myelopathies, emergency protocols, neurotoxicology and neuro-oncology.

It also includes over 100 videos, including demonstrations of neurological examinations, clinical presentations and diagnostic procedures.

Nicola Lloyd, publishing manager, said: "Whether you're a general practitioner seeking practical guidance, or a specialist aiming to refine your expertise, this edition remains an indispensable reference for anyone involved in the care of neurologically compromised dogs and cats."